DBPs in drinking water

Recent collaborative work considered THM levels in European drinking waters and the associated burden of bladder cancer. This work also demonstrates the benefit of minimized DBP levels in drinking water.

• Evlampidou, I., Font-Ribera, L., Rojas-Rueda, D., Gracia-Lavedan, E., Costet, N., Pearce, N., Vineis, P., Jaakkola, J.J.K., Delloye, F., Makris, K.C., Stephanou, E.G., Kargaki, S., Kozisek, F., Sigsgaard, T., Hansen, B., Schullehner, J., Nahkur, R., Galey, C., Zwiener, C., Vargha, M., Righi, E., Aggazzotti, G., Kalnina, G., Grazuleviciene, R., Polanska, K., Gubkova, D., Bitenc, K., Goslan, E.H., Kogevinas, M. and Villanueva, C.M. (2020) Trihalomethanes in Drinking Water and Bladder Cancer Burden in the European Union. Environmental Health Perspectives 128(1), 017001.   https://doi.org/10.1289/EHP4495

Further publications:

• Zwiener, C. (2007) Occurrence and analysis of pharmaceuticals and their transformation products in drinking water treatment. Analytical and Bioanalytical Chemistry 387(4), 1159-1162.   10.1007/s00216-006-0818-2